En Es
Categories

Industry News

Researchers Develop AI Algorithm to Predict Immunotherapy Response

By Medimaging International staff writers
12 Sep 2018

Image: Researchers have designed an AI algorithm that uses CT scan images to process medical images and extract biological and clinical information (Photo courtesy of iStock).A team of French researchers have designed an algorithm and developed it to analyze Computed Tomography (CT) scan images, establishing for the first time that artificial intelligence (AI) can process medical images to extract biological and clinical information. The researchers have created a so-called radiomic signature, which defines the level of lymphocyte infiltration of a tumor and provides a predictive score for the efficacy of immunotherapy in the patient.

In the near future, this could make it possible for physicians to use imaging to identify biological phenomena in a tumor located anywhere in the body without performing a biopsy.

Currently, there are no markers, which can accurately identify patients who will respond to anti-PD-1/PD-L1 immunotherapy in a situation where only 15 to 30% of patients do respond to such treatment. The more immunologically richer the tumor environment (presence of lymphocytes), the higher is the chances of immunotherapy being effective. Hence, the researchers tried to characterize this environment using imaging and correlate this with the patients’ clinical response. In their study, the radiomic signature was captured, developed and validated genomically, histologically and clinically in 500 patients with solid tumors (all sites) from four independent cohorts.

The researchers first used a machine learning-based approach to teach the algorithm how to use relevant information extracted from CT scans of patients participating in an earlier study, which also held tumor genome data. Thus, based solely on images, the algorithm learned to predict what the genome might have revealed about the tumor immune infiltrate, in particular with respect to the presence of cytotoxic T-lymphocytes (CD8) in the tumor, thus establishing a radiomic signature.

The researchers tested and validated this signature in other cohorts, including that of TCGA (The Cancer Genome Atlas), thus demonstrating that imaging could predict a biological phenomenon, providing an estimation of the degree of immune infiltration of a tumor. Further, in order to test the signature’s applicability in a real situation and correlate it to the efficacy of immunotherapy, it was evaluated using CT scans performed before the start of treatment in patients participating in five phase I trials of anti-PD-1/PD-L1 immunotherapy. The researchers found that the patients in whom immunotherapy was effective at three and six months had higher radiomic scores as did those with better overall survival.

In their next clinical study, the researchers will assess the signature both retrospectively and prospectively, using a larger number of patients and stratifying them based on cancer type in order to refine the signature. They will also use more sophisticated automatic learning and AI algorithms to predict patient response to immunotherapy, while integrating data from imaging, molecular biology and tissue analysis. The researchers aim to identify those patients who are most likely to respond to treatment, thereby improving the efficacy/cost ratio of treatment.



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

20 Feb 2019
RSNA Debuts New Journal Focused on AI in Radiology
The Radiological Society of North America has published the first issue of its new online journal, Radiology: Artificial Intelligence.
Read More
20 Feb 2019
Researchers Publish Chest X-Ray Dataset to Train AI Models
Researchers from the Stanford University School of Medicine have published CheXpert, a large dataset of chest X-rays and competition for automated chest X-ray interpretation, which features uncertainty labels and radiologist-labeled reference standard evaluation sets.
Read More
20 Feb 2019
ECR 2019 Debuts Artificial Intelligence Exhibition
The Artificial Intelligence Exhibition (AIX) made its grand debut at the 2019 European Congress of Radiology (ECR) annual meeting held on Feb. 27-March 3 in Vienna, Austria, bringing AI to the heart of the technical exhibition.
Read More
20 Feb 2019
AI-based Software for Chest X-rays Receives CE Certification
Oxipit, a provider of AI-based medical imaging solutions, has received CE certification for its ChestEye radiology imaging suite.
Read More
20 Feb 2019
Alliance for AI in Healthcare Formally Launched
The Alliance for Artificial Intelligence in Healthcare was formally launched following the inaugural meeting of its 22-person board of directors.
Read More
20 Feb 2019
Global Digital Pathology Market to Reach USD 600 Million by 2022
The global digital pathology market is projected to grow at a CAGR of 8.5% from 2017-2022 to reach USD 600 million by 2022, despite the presence of headwinds that are suppressing market potential and limiting its growth.
Read More
07 Feb 2019
Puritan Medical Products Kicks Off 100th Anniversary Celebrations
Puritan Medical Products Co. LLC, a global manufacturer of single-use products, is all set to celebrate its 100th anniversary this year.
Read More
07 Feb 2019
New AI System Prioritizes Chest X-Rays Containing Critical Findings
A team of UK researchers has trained an artificial intelligence (AI) system to interpret and prioritize abnormal chest X-rays with critical findings, thereby creating the potential for reducing the backlog of exams and bringing urgently needed care to patients more quickly.
Read More
07 Feb 2019
Global MRI Systems Market to Grow by USD 1.5 Billion in 2019-2023
The global MRI systems market size is projected to grow at a CAGR of more than 5%, or by almost USD 1.58 billion, during the forecast period 2019-2023, driven primarily by technological advances.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions